ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0760

X-rays Bone Erosions Are Uncommon in Anti-CCP Positive Individuals At-risk of Rheumatoid Arthritis with Musculoskeletal Symptoms Without Clinical Synovitis, and Do Not Predict the Development of Inflammatory Arthritis

Andrea Di Matteo1, Kulveer Mankia1, Jacqueline L Nam1, Edoardo Cipolletta2, Leticia Garcia-Montoya3, Laurence Duquenne1, Emma Rowbotham4 and Paul Emery5, 1University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 2Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi (AN), Italy, 3The University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK, Leeds, United Kingdom, 4Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom

Meeting: ACR Convergence 2020

Keywords: Anti-CCP, Erosions, rheumatoid arthritis, X-ray

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In individuals at-risk of RA, the identification of reliable biomarkers for the future development of clinical arthritis is of critical importance for risk-stratification and management of these individuals. Imaging, in particular US and MRI, has demonstrated the potential to predict the development and timing of RA in individuals at-risk, raising important implications on disease prevention studies.

To date, there is no consensus or guideline for the most appropriate investigations to perform in this population and clinicians would often request x-rays for the assessment of joint damage in at-risk individuals who present with hand and foot symptoms. To our knowledge, no previous study has evaluated the role of x-rays in this context. 

The aims of this study were to investigate the prevalence and distribution of bone erosions (BE) in the x-rays of the hands and feet in CCP positive (CCP+) at-risk individuals, and their association with the development of inflammatory arthritis (IA).

Methods: Baseline x-rays of the hands and feet and a full US protocol were performed as part of the current study. X-rays BE were reported as standard by MSK radiologists and confirmed by subsequent reading by a second independent MSK radiologist, blinded to the clinical and US findings. The Simple Erosions Narrowing Score (SENS) was calculated for BE. The presence of US synovitis and BE was explored in the areas in which x-rays BE were reported. A subset of CCP+ individuals (n=73) had repeated x-rays at the time of progression. Subjects with ≥1 follow-up visit were included in the progression analysis (n=394).

Results: The hands and feet x-rays of 418 CCP+ individuals were analysed. X-rays BE were found in 17 (4.1%), most frequently in the feet (64.7% individuals). The median SENS score was 2.0 (IQR: 1.0-2.0). Of the 17 CCP+ individuals with x-rays detected BE, 7 (41.2%) developed IA and 10 (58.8%) did not progress to IA. The clinical and imaging characteristics of the CCP+ individuals with x-rays BE detected are shown in Table 1.

A total of 123/394 (31.2%) CCP+ at-risk individuals developed IA (median follow-up: 336 days; IQR: 167-748). Seven out of 17 (41.2%) individuals with x-rays detected BE, and 116/377 (30.8%) individuals without x-rays detected BE, developed IA (p=0.37) (Figure 1).  New BE were found in only 4/73 (5.4%) CCP+ individuals on repeated x-rays at the time of progression.

Both in the univariable and multivariable analysis, CR detected BE were not predictive for the development of IA [OR: 1.60 (95%CI: 0.60-4.20) p=0.37 and OR: 1.00 (95%CI: 0.30-2.90) p=1.0, respectively], also when these analyses were carried out in individuals with BE in ≥ 3 joints and individuals with radiographic pattern indicating IA (according to the MSK radiologist’s diagnosis). In individuals in which BE were detected by both x-rays and US, borderline results were observed in the univariable analysis [OR=9.08 (95%CI: 1.00-82.06) p=0.05]. 

Conclusion: In CCP+ individuals at-risk of RA, x-rays BE are uncommon and do not predict the development of clinical arthritis. Prevention studies should be able at least to prevent radiographic damage in CCP+ at-risk individuals.


Disclosure: A. Di Matteo, None; K. Mankia, None; J. Nam, None; E. Cipolletta, None; L. Garcia-Montoya, None; L. Duquenne, None; E. Rowbotham, None; P. Emery, AbbVie, 2, 8, Bristol-Myers Squibb Company, 2, 8, Pfizer, 8, Roche, 2, 8, Celltrion, 8, Eli Lilly, 8, Gilead, 8, Novartis, 2, 8, Samsung, 8.

To cite this abstract in AMA style:

Di Matteo A, Mankia K, Nam J, Cipolletta E, Garcia-Montoya L, Duquenne L, Rowbotham E, Emery P. X-rays Bone Erosions Are Uncommon in Anti-CCP Positive Individuals At-risk of Rheumatoid Arthritis with Musculoskeletal Symptoms Without Clinical Synovitis, and Do Not Predict the Development of Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/x-rays-bone-erosions-are-uncommon-in-anti-ccp-positive-individuals-at-risk-of-rheumatoid-arthritis-with-musculoskeletal-symptoms-without-clinical-synovitis-and-do-not-predict-the-development-of-infla/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/x-rays-bone-erosions-are-uncommon-in-anti-ccp-positive-individuals-at-risk-of-rheumatoid-arthritis-with-musculoskeletal-symptoms-without-clinical-synovitis-and-do-not-predict-the-development-of-infla/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology